Prof. Dr. SEYFETTİN ILGAN

1. Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer

ILGAN S., Emer M. Ö., Taneri F., Aygenç E., Özbaş S., AKIN M., et al.

Frontiers in Endocrinology , cilt.17, ss.1-15, 2026 (SCI-Expanded, Scopus)

2. Sonography Could Predict Complete/Near-Complete Necrosis of Thyroid Tumors After Fine-Needle Biopsy: Necrotic Ring Sign

ILGAN S., Bilezikçi B.

Journal of Clinical Ultrasound , cilt.53, sa.3, ss.477-486, 2025 (SCI-Expanded, Scopus)

3. Exceptionally Rare Isolated Thyroidal Metastasis of Pulmonary Carcinosarcoma: A Tale of F-18 FDG-positive Thyroid Nodule

MAVİ M. E., AMİNİ F., ILGAN S.

Molecular Imaging and Radionuclide Therapy , cilt.33, 2024 (ESCI, TRDizin)

4. Sonographic Features of Atypical and Initially Missed Parathyroid Adenomas: Lessons Learned From a Single-Center Cohort

ILGAN S., Aydoǧan B., Emer Ö., Anll C., Gürsoy A., Cesur M., et al.

Journal of Clinical Endocrinology and Metabolism , cilt.109, sa.2, ss.439-448, 2024 (SCI-Expanded, Scopus)

5. Differentiation of Benign and Malignant Thyroid Nodules with ANFIS by Using Genetic Algorithm and Proposing a Novel CAD-Based Risk Stratification System of Thyroid Nodules

Ozturk A. C., Haznedar H., Haznedar B., ILGAN S., Erogul O., KALINLI A.

Diagnostics , cilt.13, sa.4, 2023 (SCI-Expanded, Scopus)

6. Early Dynamic Risk Stratification Decreases Rate of Ablative and Adjuvant Radioiodine Use in ATA Low and Intermediate Risk Papillary Thyroid Cancer Patients

GÖRÜR S. K., Özbaş S., ILGAN S.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , 2023 (ESCI, TRDizin)

7. The sonographer's and pathologist's perspective of echogenic microfoci in papillary thyroid carcinoma

Bahçecioglu A. B., Gürsoy A., SAK S., ILGAN S., Bilezikçi B., ERDOĞAN M. F.

European Thyroid Journal , cilt.12, sa.6, 2023 (SCI-Expanded, Scopus)

8. How use of radioiodine is changing according to risk groups in well differentiated thyroid cancer yi Diferansiye Tiroid Kanserlerinin Tedavisinde Risk Snflarna Göre I-131 Kullanm Nasl Degiiyor

ILGAN S.

Nuclear Medicine Seminars , cilt.7, sa.1, ss.1-32, 2021 (Scopus)

9. Radioguided occult lesion localization for minimally-invasive parathyroidectomy without quick PTH monitoring and frozen section: impact of the learning curve

SOYLU L., AYDIN O. U., ILGAN S., BİLEZİKÇİ M. B., GÜRSOY A., KOÇAK F. S.

TURKISH JOURNAL OF SURGERY , cilt.36, sa.3, ss.0-302, 2020 (ESCI, Scopus, TRDizin)

10. Contribution of 18-fluorodeoxyglucose positron emission tomography (FDG PET) imaging in the detection of underlying carcinoma in a woman with nonspecific mastitis Doprinos snimanja pozitronskom emisionom tomografijom pomoću 18-fluorodeoksiglukoze u otkrivanju skrivenog karcinoma kod žene sa nespecifičnim mastitisom

Hancerliogulları O., Ince S., Senocak R., ILGAN S., Arslan N.

Vojnosanitetski Pregled , cilt.75, sa.11, ss.1118-1122, 2018 (SCI-Expanded, Scopus)

11. The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1, N0 thyroid papillary carcinoma.

Aydin O. U., Soylu L., Ozbas S., Ilgan S., Bilezikci B., Gursoy A., et al.

European review for medical and pharmacological sciences , cilt.20, sa.9, ss.1781-7, 2016 (SCI-Expanded, Scopus)

12. The impact of the multifocality and subtypes of papillary thyroid carcinoma on central compartment lymph node metastasis

SOYLU L., AYDIN O. U., ÖZBAŞ S., BİLEZİKÇİ M. B., ILGAN S., KOÇAK F. S.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, ss.3972-3979, 2016 (SCI-Expanded, Scopus)

13. Radioguided occult lesion localization for minimally invasive parathyroidectomy: Technical consideration and feasibility

ILGAN S., Ozbas S., Bilezikci B., Sengezer T., Aydin O. U., Gursoy A., et al.

Nuclear Medicine Communications , cilt.35, sa.11, ss.1167-1174, 2014 (SCI-Expanded, Scopus)

14. Schwannomatozis of the Chest Wall: FDG PET Findings

ILGAN S., DİKMEN E., Çetinkanat C. G., DAKAK M., GÜNGÖR A.

Molecular Imaging and Radionuclide Therapy , cilt.22, 2014 (TRDizin)

15. Sonographic measurement of diuretic-induced renal length changes: Are they correlated with renal function?

Akgun V., Battal B., Kocaoglu M., Ozcan E., Akay S., ILGAN S.

Journal of Ultrasound in Medicine , cilt.31, sa.9, ss.1351-1356, 2012 (SCI-Expanded, Scopus)

16. Hydatid cyst of the liver mimicking metastasis on FDG PET/CT scan in a patient with colon cancer Kolon kanserli bir olguda FDG PET görüntülemede metastazı taklit eden karaciǧer kist hidatiǧi

Koca G., ILGAN S., Kitapçi M. T.

Gulhane Medical Journal , cilt.54, sa.3, ss.243-247, 2012 (Scopus, TRDizin)

17. The impact of FDG-PET for the preoperative management of patients with colorectal cancer FDG-PET'in kolorektal kanserli olgularda preoperatif hasta yönetimine etkisi

Kilbaş Z., Yiǧit T., ILGAN S., Arslan N., Menteş Ö., Öner K., et al.

Balkan Medical Journal , cilt.28, sa.2, ss.133-137, 2011 (Scopus)

18. Saving the zone of stasis in burns with activated protein C: An experimental study in rats

Nisanci M., Eski M., Sahin I., ILGAN S., Isik S.

Burns , cilt.36, sa.3, ss.397-402, 2010 (SCI-Expanded, Scopus)

19. Diuretic-induced renal length changes in the estimation of renal function with MR urography

Akgun V., Kocaoglu M., ILGAN S., Dayanc M., Gok F., Bulakbasi N.

American Journal of Roentgenology , cilt.194, sa.2, 2010 (SCI-Expanded, Scopus)

20. Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: A practical method for central compartment reoperations

ILGAN S., Öztürk E., Yildiz R., Emer Ö., Ayan A., Görgülü S., et al.

Clinical Nuclear Medicine , cilt.35, sa.11, ss.847-852, 2010 (SCI-Expanded, Scopus)

21. The evaluation of T1-201 myocardial perfusion scintigarphy by visual and quantitative analysis methods in the diagnosis of coronary artery disease T1-201 miyokard perfüzyon sintigrafisinin koroner arter hastaliǧindaki yerinin görsel ve sayisal analiz yöntemleri ile deǧerlendirilmesi

Serdengeçti M., ENTOK E., Sari O., ILGAN S.

Turkiye Klinikleri Cardiovascular Sciences , cilt.22, sa.1, ss.41-47, 2010 (Scopus)

22. Incidental detection of granulomatous prostatitis by F-18 FDG PET/CT in a patient with bladder cancer: A rare complication of BCG instillation therapy

ILGAN S., Koca G., Gundogdu S.

Clinical Nuclear Medicine , cilt.34, sa.9, ss.613-614, 2009 (SCI-Expanded, Scopus)

23. The role of 18f-fluoro-2-deoxyglucose positron emission tomography imaging in thyroid cancers Tiroid kanserlerinde flor-18 florodeoksiglukoz pozitron emisyon tomografi görüntülemenin yeri

Emer M. Ö., ILGAN S., Alagöz E., Arslan N., Karaçalioǧlu A. Ö., Günalp B., et al.

Gulhane Medical Journal , cilt.51, sa.4, ss.229-234, 2009 (Scopus, TRDizin)

24. Performance of acidified 14C-urea capsule breath test during pantoprazole and ranitidine treatment

Öztürk E., Yeşilova Z., ILGAN S., Özgüven M., Dab̀alp K.

Journal of Gastroenterology and Hepatology (Australia) , cilt.24, sa.7, ss.1248-1251, 2009 (SCI-Expanded, Scopus)

25. Tc-99m glutathione scintigraphy in the detection of primary tumor and staging of patients with lung cancer: A preliminary report Akciǧer kanserli hastalarda primer tümör tanisı ve evrelemede Tc-99m glutatyon sintigrafisinin rolü: Ön sonuçlar

Karaçalioǧlu A., Özkan M., ILGAN S., Arslan N., Özgüven M. A.

Gulhane Medical Journal , cilt.51, sa.4, ss.235-238, 2009 (Scopus, TRDizin)

26. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: A 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia

Uygun A., Kadayifci A., Yesilova Z., Safali M., ILGAN S., Karaeren N.

Clinical Therapeutics , cilt.30, sa.3, ss.528-534, 2008 (SCI-Expanded, Scopus)

27. Bilateral femoral insuffiency fractures treated with inflatable intramedullary nails: A case report

Demiralp B., ILGAN S., Ozgur Karacalioglu A., Cicek E. I., Yildrim D., Erler K.

Archives of Orthopaedic and Trauma Surgery , cilt.127, sa.7, ss.597-601, 2007 (SCI-Expanded, Scopus)

28. Massive inguinoscrotal herniation of the bladder with ureter: Incidental demonstration on bone scan

ILGAN S., Ozguven M., Emer M. O., Karacalioglu A. O.

Annals of Nuclear Medicine , cilt.21, sa.6, ss.371-373, 2007 (SCI-Expanded, Scopus)

29. Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.

Uygun A., Kadayifci A., Yesilova Z., Ates Y., Safali M., Ilgan S., et al.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology , cilt.26, sa.4, ss.174-7, 2007 (Scopus)

30. Assessment of distraction regenerate using quantitative bone scintigraphy

Eski M., ILGAN S., Cil Y., Sengezer M., Ozcan A., Yapici K.

Annals of Plastic Surgery , cilt.58, sa.3, ss.328-334, 2007 (SCI-Expanded, Scopus)

31. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori

Uygun A., Kadayifci A., Safali M., ILGAN S., Bagci S.

Journal of Digestive Diseases , cilt.8, sa.4, ss.211-215, 2007 (Scopus)

32. Rosai-Dorfman disease of the parotid and submandibular glands: Salivary gland scintigraphy and oral findings in two siblings

Güven G., ILGAN S., Altun C., Gerek M., Gunhan O.

Dentomaxillofacial Radiology , cilt.36, sa.7, ss.428-433, 2007 (SCI-Expanded, Scopus)

33. A physiologic approach to decreasing upward creep of the heart during myocardial perfusion imaging.

Karacalioglu A. O., Jata B., Kilic S., Arslan N., Ilgan S., Ozguven M. A.

Journal of nuclear medicine technology , cilt.34, sa.4, ss.215-9, 2006 (Scopus)

34. Disseminated metastatic disease of osteosarcoma of the femur in the abdomen: Unusual metastatic pattern on Tc-99m MDP bone scan

Karacalioglu O., ILGAN S., Kuzhan O., Emer O., Ozguven M.

Annals of Nuclear Medicine , cilt.20, sa.6, ss.437-440, 2006 (SCI-Expanded, Scopus)

35. Scintigraphic imaging of endothelium-dependent vasodilation in the forearm - A preliminary report

Karacalioglu A. O., Demirkol S., Emer O., Celik T., Kilic S., ILGAN S., et al.

Circulation Journal , cilt.70, sa.3, ss.311-315, 2006 (SCI-Expanded, Scopus)

36. Investigation of the effect of the reversible myocardial ischemia on serum levels of biochemical indicators associated with myocardial injury Geri dönüşümlü iskeminin miyokard hasari ile ilgili biyokimyasal belirteçlerin serum düzeyleri üzerine olan etkisinin araştirilmasi

Karaçalioǧlu A. Ö., Kiliç S., Çelik T., Arslan Z., Yaman H., ILGAN S., et al.

Gulhane Medical Journal , cilt.48, sa.2, ss.87-93, 2006 (Scopus, TRDizin)

37. The effects of tangential radiotherapy on lung clearance in breast cancer patients

Yüksel D., Sürenkök S., ILGAN S., Öztürk E., Pak Y.

Radiotherapy and Oncology , cilt.77, sa.3, ss.262-266, 2005 (SCI-Expanded, Scopus)

38. Fused pelvic kidneys: "Hourglass sign" on Tc-99m DTPA diuresis renography

Karacalioglu O., ILGAN S., Arslan N., Emer O., Ozguven M.

Annals of Nuclear Medicine , cilt.19, sa.4, ss.313-316, 2005 (SCI-Expanded, Scopus)

39. Varices of inferior epigastric veins caused by chronic inferior vena cava obstruction: Mimicking normal venous flow pattern on radionuclide venography

Karacalioglu O., Sonmez A., ILGAN S., Soylu K., Emer O., Ozguven M.

Annals of Nuclear Medicine , cilt.19, sa.3, ss.235-238, 2005 (SCI-Expanded, Scopus)

40. Unilateral temporary functional stasis in the upper urinary tract caused by "a filled bladder" on Tc-99m DTPA diuresis renography: A teaching case

Karacalioglu O., ILGAN S., Arslan N., Emer O., Ozguven M.

Annals of Nuclear Medicine , cilt.19, sa.6, ss.511-514, 2005 (SCI-Expanded, Scopus)

41. Combined Tc-99m MDP and Tc-99m labeled RBC imaging in a case of Maffucci's syndrome

Karacalioglu O., Gunalp B., ILGAN S., Arslan N., Ozguven M. A.

Clinical Nuclear Medicine , cilt.29, sa.12, ss.817-820, 2004 (SCI-Expanded, Scopus)

42. Unusual patterns of I-131 accumulation

Ozguven M., ILGAN S., Karacalioglu A. O., Arslan N., Ozturk E.

Clinical Nuclear Medicine , cilt.29, sa.11, ss.738-740, 2004 (SCI-Expanded, Scopus)

43. Diagnostic difficulty in interpretation of Tc-99m MAG3 dynamic renal scan: Intrarenal reflux or delayed concentration function?

Karacalioglu O., ILGAN S., Arslan N., Ozguven M. A., Dayanc M.

Clinical Nuclear Medicine , cilt.29, sa.6, ss.382-385, 2004 (SCI-Expanded, Scopus)

44. Iodine-131 treatment and high-resolution CT: Results in patients with lung metastases from differentiated thyroid carcinoma

ILGAN S., Karacalioglu A. O., Pabuscu Y., Atac G. K., Arslan N., Ozturk E., et al.

European Journal of Nuclear Medicine and Molecular Imaging , cilt.31, sa.6, ss.825-830, 2004 (SCI-Expanded, Scopus)

45. Unusual patterns of I-131 contamination

Ozguven M., ILGAN S., Arslan N., Karacalioglu A. O., Yuksel D., Dundar S.

Annals of Nuclear Medicine , cilt.18, sa.3, ss.271-274, 2004 (SCI-Expanded, Scopus)

46. A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: Clinical validation and comparison with the standard method

Öztürk E., Yeşilova Z., ILGAN S., Arslan N., Erdil A., Celasun B., et al.

European Journal of Nuclear Medicine and Molecular Imaging , cilt.30, sa.11, ss.1457-1462, 2003 (SCI-Expanded, Scopus)

47. Uterine doughnut in early proliferating phase: Potential pitfall in gastrointestinal bleeding studies

Karacalioglu O., ILGAN S., Arslan N., Ozguven M.

Annals of Nuclear Medicine , cilt.17, sa.8, ss.685-687, 2003 (SCI-Expanded, Scopus)

48. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.

Serdar M. A., Oguz O., Olgun A., Seçkin B., Ilgan S., Hasimi A., et al.

Annals of clinical and laboratory science , cilt.32, sa.1, ss.22-30, 2002 (SCI-Expanded, Scopus)

49. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery

Arslan N., ILGAN S., Yuksel D., Serdengecti M., Bulakbasi N., UĞUR Ö., et al.

Clinical Nuclear Medicine , cilt.26, sa.8, ss.683-688, 2001 (SCI-Expanded, Scopus)

50. A practical approach to glomerular filtration rate measurements: creatinine clearance estimation using cimetidine.

Serdar M. A., Kurt I., Ozcelik F., Urhan M., Ilgan S., Yenicesu M., et al.

Annals of clinical and laboratory science , cilt.31, sa.3, ss.265-73, 2001 (SCI-Expanded, Scopus)

51. Post-surgical ablation of thyroid remnants with high-dose 131i in patients with differentiated thyroid carcinoma

Arslan N., ILGAN S., Serdengecti M., Ozguven M., Bayhan H., Okuyucu K., et al.

Nuclear Medicine Communications , cilt.22, sa.9, ss.1021-1027, 2001 (SCI-Expanded, Scopus)

52. Utility of ventilation and perfusion scan in the diagnosis of young military recruits with an incidental finding of hyperlucent lung

Arslan N., ILGAN S., Ozkan M., Yuksekol I., Bulakbasi N., Pabuscu Y., et al.

Nuclear Medicine Communications , cilt.22, sa.5, ss.525-530, 2001 (SCI-Expanded, Scopus)

53. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy

Yüksel D., ILGAN S., Arslan N., UĞUR Ö., Oztürk E., Bayhan H.

Clinical Nuclear Medicine , cilt.25, sa.3, ss.193-196, 2000 (SCI-Expanded, Scopus)

54. Congenital septal aneurysm: A rare cause of fixed defect on myocardial perfusion spect

ILGAN S., Ilgenli T. F., Karaçalioǧlu Ö., Karaeren H., Arslan N., Bayhan H.

Clinical Nuclear Medicine , cilt.25, sa.1, ss.60-61, 2000 (SCI-Expanded, Scopus)

55. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis

Arslan N., SERDAR M. A., Deveci S., Ozturk B., Narin Y., ILGAN S., et al.

Annals of Nuclear Medicine , cilt.14, sa.5, ss.395-399, 2000 (Scopus)

56. The comparison of dual phase Tc-99m MIBI and Tc-99m MDP scintimammography in the evaluation of breast masses: Preliminary report

Arslan N., Ozturk E., ILGAN S., Narin Y., Dundar S., Tufan T., et al.

Annals of Nuclear Medicine , cilt.14, sa.1, ss.39-46, 2000 (Scopus)

57. Altered biodistribution of Tc-99m MDP in a uremic and severely malnourished patient supported with enteral nutritional feeding

Arslan N., ILGAN S., Karacalioglu A., Ozturk E., Bayhan H.

Clinical Nuclear Medicine , cilt.24, sa.12, ss.993-994, 1999 (SCI-Expanded, Scopus)

58. The importance of patient positioning in the detection of axillary lymphatic involvement with Tc-99m sestamibi scintimammography

Arslan N., Ozturk E., ILGAN S., Bayhan H.

Clinical Nuclear Medicine , cilt.24, sa.11, ss.884-885, 1999 (SCI-Expanded, Scopus)

59. Warthin's tumor and I-131 body scan

ILGAN S., Narin Y., Arslan N., Aksu A., Bayhan H.

Clinical Nuclear Medicine , cilt.24, sa.9, ss.721-722, 1999 (SCI-Expanded, Scopus)

60. Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole

Yang D. J., ILGAN S., Higuchi T., Zareneyrizi F., Oh C., Liu C., et al.

Pharmaceutical Research , cilt.16, sa.5, ss.743-750, 1999 (SCI-Expanded, Scopus)

61. Wharton duct pseudodiverticulum: An unusual cause of misdiagnosis with salivary gland scintigraphy

ILGAN S., Atac K., Pabuscu Y., Bayhan H.

Clinical Nuclear Medicine , cilt.24, sa.1, ss.74-75, 1999 (SCI-Expanded, Scopus)

62. Biodistribution and scintigraphy of [111In]DTPA-adriamycin in mammary tumor-bearing rats

Higuchi T., Yang D. J., ILGAN S., Tansey L. W., Zareneyrizi F., Inoue T., et al.

Anti-Cancer Drugs , cilt.10, sa.1, ss.89-95, 1999 (SCI-Expanded, Scopus)

63. Synthesis of [99mTc]ethylenedicysteine-colchicine for evaluation of antiangiogenic effect

Zareneyrizi F., Yang D. J., Oh C., ILGAN S., Yu D., Tansey W., et al.

Anti-Cancer Drugs , cilt.10, sa.7, ss.685-692, 1999 (SCI-Expanded, Scopus)

64. Biodistribution and imaging of polyethyleneimine - A gene delivery agent

Nichol C. A., Yang D., Humphrey W., ILGAN S., Tansey W., Higuchi T., et al.

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents , cilt.6, sa.3, ss.187-194, 1999 (SCI-Expanded, Scopus)

65. 99Tcm-mibi scintimammography in the evaluation of breast lesions and axillary involvement a comparison with mammography and histopathological diagnosis

Arslan N., OztüRk E., ILGAN S., Urhan M., Karagalioglu Ö., Bayhan H., et al.

Nuclear Medicine Communications , cilt.20, sa.4, ss.317-326, 1999 (SCI-Expanded, Scopus)

66. Interventricular septal aneurysm: A case report

Karaeren H., Ilgenli T. F., Uzun M., ILGAN S., Erinç K., Iyisoy A., et al.

Echocardiography , cilt.16, sa.7 I, ss.667-669, 1999 (SCI-Expanded, Scopus)

67. Imaging tumor folate receptors using radiolabeled folate and methotrexate

Yang D., Zakko S., Boulfelfel J., Shamsi H., ILGAN S., Yu D., et al.

Journal of Labelled Compounds and Radiopharmaceuticals , cilt.42, sa.SUPPL. 1, 1999 (SCI-Expanded, Scopus)

68. Saving the zone of stasis in burns with recombinant tissue-type plasminogen activator (r-tPA): An experimental study in rats

Işik S., Şahin Ü., ILGAN S., Güler M., Günalp B., Selmanpakoǧlu N.

Burns , cilt.24, sa.3, ss.217-223, 1998 (SCI-Expanded, Scopus)

69. 99mTc-EthyIenedicysteine-Folate: A new tumor imaging agent. synthesis, labeling and evaluation in animals

ILGAN S., Yang D. J., Higuchi T., Zareneyrizi F., Bayhan H., Edmund Kim E., et al.

Cancer Biotherapy and Radiopharmaceuticals , cilt.13, sa.6, ss.427-435, 1998 (SCI-Expanded, Scopus)

70. Discordance of sialography and scintigraphy in unilateral chronic sialadenitis.

Ilgan S., Ataç K., Oztürk E., Pabusçu Y., Bayhan H.

Nuklearmedizin. Nuclear medicine , cilt.37, sa.6, ss.218-20, 1998 (SCI-Expanded, Scopus)

71. Imaging tumor folate receptors using 111In-DTPA-methotrexate

ILGAN S., Yang D. J., Higuchi T., Zareneyrizi F., Kim E. E., Podoloff D. A.

Cancer Biotherapy and Radiopharmaceuticals , cilt.13, sa.3, ss.177-184, 1998 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Toplam Atıf Sayısı